{"Title": "Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial", "Year": 2017, "Source": "J. Natl. Cancer Inst.", "Volume": "109", "Issue": 9, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 119, "DOI": "10.1093/jnci/djx015", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017200980&origin=inward", "Abstract": "\u00a9 2017 The Author 2017. Published by Oxford University Press.Background: Tumor ablation is often employed for unresectable colorectal liver metastases. However, no survival benefit has ever been demonstrated in prospective randomized studies. Here, we investigate the long-term benefits of such an aggressive approach. Methods: In this randomized phase II trial, 119 patients with unresectable colorectal liver metastases (n < 10 and no extrahepatic disease) received systemic treatment alone or systemic treatment plus aggressive local treatment by radiofrequency ablation \u00b1 resection. Previously, we reported that the primary end point (30-month overall survival [OS] > 38%) was met. We now report on long-term OS results. All statistical tests were two-sided. The analyses were according to intention to treat. Results: At a median follow up of 9.7 years, 92 of 119 (77.3%) patients had died: 39 of 60 (65.0%) in the combined modality arm and 53 of 59 (89.8%) in the systemic treatment arm. Almost all patients died of progressive disease (35 patients in the combined modality arm, 49 patients in the systemic treatment arm). There was a statistically significant difference in OS in favor of the combined modality arm (hazard ratio [HR] = 0.58, 95% confidence interval [CI] = 0.38 to 0.88, P =. 01). Three-, five-, and eight-year OS were 56.9% (95% CI = 43.3% to 68.5%), 43.1% (95% CI = 30.3% to 55.3%), 35.9% (95% CI = 23.8% to 48.2%), respectively, in the combined modality arm and 55.2% (95% CI = 41.6% to 66.9%), 30.3% (95% CI = 19.0% to 42.4%), 8.9% (95% CI = 3.3% to 18.1%), respectively, in the systemic treatment arm. Median OS was 45.6 months (95% CI = 30.3 to 67.8 months) in the combined modality arm vs 40.5 months (95% CI = 27.5 to 47.7 months) in the systemic treatment arm. Conclusions: This phase II trial is the first randomized study demonstrating that aggressive local treatment can prolong OS in patients with unresectable colorectal liver metastases.", "AuthorKeywords": null, "IndexKeywords": ["Adult", "Aged", "Antineoplastic Combined Chemotherapy Protocols", "Catheter Ablation", "Chemotherapy, Adjuvant", "Colorectal Neoplasms", "Disease-Free Survival", "Fluorouracil", "Humans", "Leucovorin", "Liver Neoplasms", "Middle Aged", "Neoplasm Staging", "Organoplatinum Compounds"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85017200980", "SubjectAreas": [["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"7006732610": {"Name": "Ruers T.", "AuthorID": "7006732610", "AffiliationID": "60015205", "AffiliationName": "Division of Surgical Oncology, Netherlands Cancer Institute"}, "7004520178": {"Name": "Van Coevorden F.", "AuthorID": "7004520178", "AffiliationID": "60015205, 60070177", "AffiliationName": "Netherlands Cancer Institute, Antoni Van Leeuwenhoek Ziekenhuis"}, "6603539789": {"Name": "Verwaal V.J.", "AuthorID": "6603539789", "AffiliationID": "60015205, 60070177", "AffiliationName": "Netherlands Cancer Institute, Antoni Van Leeuwenhoek Ziekenhuis"}, "7004571924": {"Name": "Punt C.J.A.", "AuthorID": "7004571924", "AffiliationID": "60002483, 60001157", "AffiliationName": "Academic Medical Centre, University of Amsterdam"}, "8656937000": {"Name": "Pierie J.P.E.N.", "AuthorID": "8656937000", "AffiliationID": "60070191", "AffiliationName": "Leeuwarden Medical Center"}, "7004195270": {"Name": "Borel-Rinkes I.", "AuthorID": "7004195270", "AffiliationID": "60032724", "AffiliationName": "Universitair Medisch Centrum, Academisch Ziekenhuis"}, "7007134127": {"Name": "Ledermann J.A.", "AuthorID": "7007134127", "AffiliationID": "60027403, 60012754, 60024544, 60022148", "AffiliationName": "Cancer Research UK, UCL Cancer Trials Centre, University College Hospital, UCL Hospitals"}, "22955548300": {"Name": "Gillams A.", "AuthorID": "22955548300", "AffiliationID": "60027403, 60012754, 60024544, 60022148", "AffiliationName": "Cancer Research UK, UCL Cancer Trials Centre, University College Hospital, UCL Hospitals"}, "35481299900": {"Name": "Poston G.", "AuthorID": "35481299900", "AffiliationID": "60014875", "AffiliationName": "Aintree University Hospital"}, "35405651700": {"Name": "Bechstein W.", "AuthorID": "35405651700", "AffiliationID": "60009308", "AffiliationName": "Frankfurt University Hospital and Clinics"}, "7006264276": {"Name": "Lentz M.A.", "AuthorID": "7006264276", "AffiliationID": "60009434", "AffiliationName": "EORTC Headquarters, Statistics Department"}, "24166722500": {"Name": "Mauer M.", "AuthorID": "24166722500", "AffiliationID": "60009434", "AffiliationName": "EORTC Headquarters, Statistics Department"}, "6601967125": {"Name": "Folprecht G.", "AuthorID": "6601967125", "AffiliationID": "60025676", "AffiliationName": "University Cancer Center, University Hospital Carl Gustav Carus"}, "57212668756": {"Name": "Van Cutsem E.", "AuthorID": "57212668756", "AffiliationID": "60031069, 60025063", "AffiliationName": "Digestive Oncology, University Hospitals Gasthuisberg, KU Leuven"}, "55613231547": {"Name": "Ducreux M.", "AuthorID": "55613231547", "AffiliationID": "60027386", "AffiliationName": "Institut Gustave Roussy"}, "7101766379": {"Name": "Nordlinger B.", "AuthorID": "7101766379", "AffiliationID": "60021567", "AffiliationName": "Assistance Publique H\u00f4pitaux de Paris"}, "57193871196": {"Name": "Par\u00e9 A.", "AuthorID": "57193871196", "AffiliationID": "60021567", "AffiliationName": "Assistance Publique H\u00f4pitaux de Paris"}, "6603768510": {"Name": "Gruenberger T.", "AuthorID": "6603768510", "AffiliationID": "60011394, 60026929", "AffiliationName": "Medical University Vienna, General Hospital"}, "7004822334": {"Name": "Klaase J.", "AuthorID": "7004822334", "AffiliationID": "60005675", "AffiliationName": "Medisch Spectrum Twente"}, "57204301812": {"Name": "Falk S.", "AuthorID": "57204301812", "AffiliationID": "60024764, 60170515", "AffiliationName": "University Hospitals Bristol NHS Foundation Trust, Bristol Haematology and Oncology Centre"}, "9842837800": {"Name": "Wals J.", "AuthorID": "9842837800", "AffiliationID": "60002051", "AffiliationName": "Atrium Medisch Centrum"}, "8056783500": {"Name": "Jansen R.L.", "AuthorID": "8056783500", "AffiliationID": "107163955", "AffiliationName": "Akademisch Ziekenhuis Maastricht"}, "7102286760": {"Name": "Lindn\u00e9r P.", "AuthorID": "7102286760", "AffiliationID": "60031699", "AffiliationName": "Sahlgrenska Sjukhuset"}, "6603014007": {"Name": "Mulier S.", "AuthorID": "6603014007", "AffiliationID": "60070063", "AffiliationName": "Cliniques Universitaires de Mont Godinne"}, "6701485503": {"Name": "Bosscha K.", "AuthorID": "6701485503", "AffiliationID": "60070246", "AffiliationName": "Jeroen Bosch Ziekenhuis"}, "16750524200": {"Name": "Jaeck D.", "AuthorID": "16750524200", "AffiliationID": "60010247", "AffiliationName": "H\u00f4pital Universitaire Hautepierre"}, "7201979066": {"Name": "Arnaud J.P.", "AuthorID": "7201979066", "AffiliationID": "60009445", "AffiliationName": "Centre Hospitalier Universitaire d'Angers"}, "8112966700": {"Name": "Smith D.", "AuthorID": "8112966700", "AffiliationID": "60020939", "AffiliationName": "Clatterbridge Centre for Oncology NHS Trust"}, "7006628840": {"Name": "Sherlock D.", "AuthorID": "7006628840", "AffiliationID": "60007321", "AffiliationName": "North Manchester General Hospital"}, "7005750862": {"Name": "Ammori B.", "AuthorID": "7005750862", "AffiliationID": "60030886", "AffiliationName": "Manchester Royal Infirmary"}, "6508275735": {"Name": "El-Serafi M.", "AuthorID": "6508275735", "AffiliationID": "60015151", "AffiliationName": "National Cancer Institute"}, "56457740000": {"Name": "Glimelius B.", "AuthorID": "56457740000", "AffiliationID": "60019295", "AffiliationName": "Karolinska University Hospital Solna"}, "7005407649": {"Name": "Hellman P.", "AuthorID": "7005407649", "AffiliationID": "60015216", "AffiliationName": "Akademiska Sjukhuset"}, "null": {"Name": null, "AuthorID": null, "AffiliationID": null, "AffiliationName": null}}}